New drug trial aims to halt diabetic vision loss
Disease control
Not yet recruiting
This study is testing if a new drug called AVT29 is as effective and safe as the standard treatment, Eylea HD, for diabetic macular edema, a condition that causes vision loss. About 256 adults with this specific type of vision loss from diabetes will be randomly assigned to recei…
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC